Skip to main content Scroll Top
Most Viewed Posts
Clear Filters
“Conceiving an innovation is one thing; bringing it to fruition is quite another.” Guillaume Blivet wants to transform the lives of patients with neurological disorders
A promising new treatment for concussion and Alzheimer’s victims?
REGEnLIFE tests light stimulation on neurodegenerative diseases

Alzheimer’s disease: the promise of new Non-Invasive Brain Stimulation methods

17th edition of the Francophone Meetings on Alzheimer’s Disease and Related Syndromes (RFMASA) / 29 September to 1 October 2025 (LAUSANNE – SWITZERLAND)

Guillaume Blivet 1; Thomas Sacrez 2; Gizem Temiz 3; Michael Weiner 4; Marwan Sabbagh 5; Jacques Touchon 2 ; Jeffrey Cummings 6

1 REGEnLIFE, Montpellier, France; 2 University of Montpellier, Montpellier, France; 3 TheraPanacea SAS, Paris, France; 4 University of San Francisco, San Francisco, California, USA; 5 Barrow Neurological Institute, Phoenix, Arizona, USA; 6 University of Nevada, Las Vegas, Las Vegas, Nevada, USA.

Share this article